News round-up for 15-19 May by DDW Digital Content Editor Diana Spencer.
It’s Clinical Trials Day tomorrow and this week we have reported on the launch of a number of new Phase I trials. In-human studies have been initiated to test treatments for Parkinson’s disease, radioactive contamination, Dravet Syndrome, influenza and inflammatory diseases.
The top stories:
A study that could lead to the development of new treatments for Parkinson’s disease has launched at the University of Dundee, Scotland.
A first-in-human clinical trial of an experimental oral drug for removing radioactive contaminants from inside the body has begun.
Bloom Science has completed enrolment in all four cohorts of healthy adult participants as part of its Phase I clinical trial.
A clinical trial of an experimental universal influenza vaccine has begun enrolling volunteers at Duke University in Durham, North Carolina.
Scotland-based Kynos Therapeutics has launched a first-in-human Phase I trial of its kynurenine 3-monooxygenase (KMO) inhibitor KNS366.